Higher-Risk Chronic Myelomonocytic Leukemia Treatment Market, Pipeline, Epidemiology, Drugs, and Companies by DelveInsight | Argenx, Novartis, Kura Oncology, Sensei Biotherapeutics, Takeda and Ma